# Sotera Health (SHC) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/SHC
## Company Profile
- Ticker: SHC
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 17.98 USD
- Market cap: 4283208249.88 USD
- Last updated: 2026-08-05
## Business Overview
### Healthcare Sterilization Infrastructure
Sotera Health provides sterilization, laboratory testing and advisory services that support the safety and regulatory compliance of medical devices, pharmaceuticals and other healthcare products. Its businesses operate at critical points between product manufacturing and release to customers.
### Sterigenics
Sterigenics provides outsourced terminal sterilization using multiple technologies and a global network of facilities. Medical-device and pharmaceutical manufacturers rely on these services for validated, high-throughput treatment of finished products.
### Nordion
Nordion supplies cobalt-60 and related technologies used in gamma sterilization. This business supports both Sotera’s broader sterilization ecosystem and third-party operators that depend on a stable source of irradiation material.
### Nelson Labs
Nelson Labs provides microbiological, analytical and product-validation testing, together with expert advisory services. The laboratory network helps healthcare manufacturers demonstrate product safety, performance and compliance throughout development and commercialization.
## Why The Stock Is Moving

The latest monitored company update is “Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- Sotera Health's catalysts are sterilization volumes, lab-testing demand, and the pace at which litigation overhang continues to fade. The company tends to re-rate when the core franchise looks more predictable and the headline risk gets less distracting.

## Recent News
- 2026-08-06 11:00 EST — [Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook](https://biopharmsignal.com/news/SHC/sotera-health-delivers-strong-second-quarter-and-first-half-2026-results-and-rai-0dfdcd0f) — Source: Sotera Health
- 2026-07-23 11:00 EST — [Sotera Health Announces Second-Quarter 2026 Earnings Release Date](https://biopharmsignal.com/news/SHC/sotera-health-announces-second-quarter-2026-earnings-release-date-978177a2) — Source: Sotera Health
- 2026-05-11 20:33 EST — [Sotera Health Announces Secondary Offering of Common Stock](https://biopharmsignal.com/news/SHC/sotera-health-announces-secondary-offering-of-common-stock-f691dd2e) — Source: Sotera Health
- 2026-05-05 11:04 EST — [Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook](https://biopharmsignal.com/news/SHC/sotera-health-delivers-strong-first-quarter-2026-results-and-reaffirms-2026-outlook) — Source: Sotera Health
- 2026-05-05 11:00 EST — [Sotera Health Announces Leadership Transition](https://biopharmsignal.com/news/SHC/sotera-health-announces-leadership-transition) — Source: Sotera Health